Circulating Tumor Cell (CTC) Filtration Technology ID: 2015-028
This technology represents a breakthrough in early detection of pancreatic cancer through advanced filtration of circulating tumor cells.
Photo by starlineart - stock.adobe.com
Technology Overview
The document details the development of a novel CTC filtration technology aimed at enriching circulating tumor cells from blood samples, specifically for pancreatic cancer detection. Utilizing carbon nanotube templated microfabrication, the technology promises a high open-area filter capable of processing large volumes with minimal contamination, crucial for effective biomarker detection.
Key Advantages
- High open-area polymeric filters increase sample throughput
- Low contamination levels, essential for accurate biomarker amplification
- Cost-effective manufacturing process compared to traditional lithographic filters
- Potential for high-yield, low-contamination results in clinical settings
Problems Addressed
- Challenges in capturing circulating tumor cells efficiently for pancreatic cancer
- Limitations in filter capacity and contamination in existing technologies
- High manufacturing costs of advanced filtration technologies
Additional Information
Technology ID: 2015-028
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 28 March, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report